Procurement Summary
Country: Kazakhstan
Summary: Purchase of Medicines, Amt: 1156359.00
Deadline: 01 Jun 2026
Posting Date: 29 May 2026
Other Information
Notice Type: Tender
TOT Ref.No.: 142231884
Document Ref. No.: 17083506-1
Competition: ICB
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: KZT 1156359.00
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_details
Login to see detailsTender Details
Lots: Caffeine-sodium benzoate - Caffeine-sodium benzoate solution 20% 1 ml No. 10, Caffeine-sodium benzoate solution one ampoule (1 ml) contains: active substance - caffeine-sodium benzoate - 200 mg excipients: 0.1 M sodium hydroxide solution, water for injection Description: Transparent, colorless or slightly yellowish liquid. Pharmacotherapeutic group. Nervous system. Psychoanaleptics. Psychostimulants used for attention deficit and hyperactivity disorder. Xanthine derivatives. Caffeine. ATX code N06B C01 | Nifedipine tablets 10 mg No. 50, Film-coated tablets, 10 mg and 20 mg One tablet contains the active substance: nifedipine - 10 mg or 20 mg; excipients: lactose monohydrate, potato starch, microcrystalline cellulose, povidone, sodium lauryl sulfate, magnesium stearate, hypromelose (hydroxypropyl methylcellulose), polysorbate 80, titanium dioxide (E 171), polyethylene glycol 6000, talc, quinoline yellow (E 104). Round, biconvex, film-coated tablets yellow color. On a fault, when viewed under a magnifying glass, a core is visible, surrounded by one continuous layer. Calcium channel blockers. Selective calcium channel blockers with a predominant effect on blood vessels. Dihydropyridine derivatives. Nifedipine. ATX code C08CA05 Film-coated tablets, 10 mg and 20 mg. 10 tablets each in a blister pack made of polyvinyl chloride film and rolled packaging material based on aluminum foil. 5 contour cell...
Documents
Tender Notice